BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15907714)

  • 1. Medical care cost of patients with prostate cancer.
    Jayadevappa R; Chhatre S; Weiner M; Bloom BS; Malkowicz SB
    Urol Oncol; 2005; 23(3):155-62. PubMed ID: 15907714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial differences in the cost of treating men with early-stage prostate cancer.
    Brandeis J; Pashos CL; Henning JM; Litwin MS
    J Am Geriatr Soc; 2001 Mar; 49(3):297-303. PubMed ID: 11300241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of conservative management of early-stage prostate cancer compared to radical prostatectomy-a claims data analysis.
    Brandes A; Koerber F; Schwarzkopf L; Hunger M; Rogowski WH; Waidelich R
    BMC Health Serv Res; 2016 Nov; 16(1):664. PubMed ID: 27863486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
    Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
    JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and ethnic variation in health resource use and cost for prostate cancer.
    Jayadevappa R; Malkowicz SB; Chhatre S; Gallo J; Schwartz JS
    BJU Int; 2010 Sep; 106(6):801-8. PubMed ID: 20151963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health related quality of life and direct medical care cost in newly diagnosed younger men with prostate cancer.
    Jayadevappa R; Bloom BS; Chhatre S; Fomberstein KM; Wein AJ; Malkowicz SB
    J Urol; 2005 Sep; 174(3):1059-64; discussion 1064. PubMed ID: 16094058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical Prostatectomy.
    Martini A; Marqueen KE; Falagario UG; Waingankar N; Wajswol E; Khan F; Fossati N; Briganti A; Montorsi F; Tewari AK; Stock R; Rastinehad AR
    JAMA Netw Open; 2020 Mar; 3(3):e201913. PubMed ID: 32232450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Income inequality and treatment of African American men with high-risk prostate cancer.
    Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
    Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial disparities in lymph node dissection at radical prostatectomy: A Surveillance, Epidemiology and End Results database analysis.
    Preisser F; Nazzani S; Bandini M; Marchioni M; Tian Z; Saad F; Chun FK; Shariat SF; Montorsi F; Huland H; Graefen M; Tilki D; Karakiewicz PI
    Int J Urol; 2018 Nov; 25(11):929-936. PubMed ID: 30146729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between race and oncologic outcome following radical prostatectomy for clinically organ-confined prostate cancer: a long-term follow-up study.
    Amini E; Palmer TC; Cai J; Lieskovsky G; Daneshmand S; Djaladat H
    World J Urol; 2018 Aug; 36(8):1233-1239. PubMed ID: 29536157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
    Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
    JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity.
    Underwood W; Wei J; Rubin MA; Montie JE; Resh J; Sanda MG
    Urol Oncol; 2004; 22(1):20-4. PubMed ID: 14969799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer.
    Cullen J; Lynch JA; Klein EA; Van Den Eeden SK; Carroll PR; Mohler JL; Knezevic D; Farrington TA; Lu R
    J Urol; 2021 Apr; 205(4):1047-1054. PubMed ID: 33493001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of aggressive therapy for nonmetastatic prostate carcinoma in Massachusetts from 1998 to 2002.
    Rose AJ; Backus BM; Gershman ST; Santos P; Ash AS; Battaglia TA
    Med Care; 2007 May; 45(5):440-7. PubMed ID: 17446830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
    Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
    JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
    Shavers VL; Brown M; Klabunde CN; Potosky AL; Davis W; Moul J; Fahey A
    Med Care; 2004 Mar; 42(3):239-50. PubMed ID: 15076823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends and black/white differences in treatment for nonmetastatic prostate cancer.
    Klabunde CN; Potosky AL; Harlan LC; Kramer BS
    Med Care; 1998 Sep; 36(9):1337-48. PubMed ID: 9749657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O; Ikuemonisan J; Salami SS; Adejoro O
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative cost pattern comparison of prostate cancer treatments.
    Wilson LS; Tesoro R; Elkin EP; Sadetsky N; Broering JM; Latini DM; DuChane J; Mody RR; Carroll PR
    Cancer; 2007 Feb; 109(3):518-27. PubMed ID: 17186528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.